PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection

Emerging strategies that center upon the mammalian target of rapamycin (mTOR) signaling for neurodegenerative disorders may bring effective treatment for a number of difficult disease entities. Here we show that erythropoietin (EPO), a novel agent for nervous system disorders, prevents apoptotic SH-SY5Y cell injury in an oxidative stress model of oxygen-glucose deprivation through phosphatidylinositol-3-kinase (PI 3-K)/protein kinase B (Akt) dependent activation of mTOR signaling and phosphorylation of the downstream pathways of p70 ribosomal S6 kinase (p70S6K), eukaryotic initiation factor 4E-binding protein 1 (4EBP1), and proline rich Akt substrate 40 kDa (PRAS40). PRAS40 is an important regulatory component either alone or in conjunction with EPO signal transduction that can determine cell survival through apoptotic caspase 3 activation. EPO and the PI 3-K/Akt pathways control cell survival and mTOR activity through the inhibitory post-translational phosphorylation of PRAS40 that leads to subcellular binding of PRAS40 to the cytoplasmic docking protein 14-3-3. However, modulation and phosphorylation of PRAS40 is independent of other protective pathways of EPO that involve extracellular signal related kinase (ERK 1/2) and signal transducer and activator of transcription (STAT5). Our studies highlight EPO and PRAS40 signaling in the mTOR pathway as potential therapeutic strategies for development against degenerative disorders that lead to cell demise.

• Publication year

  2012

• Venue

  PLoS ONE

• Publication date

  2012-09-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0045456PMID 23029019PMCID 3445503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Knockdown of RON Inhibits AP-1 Activity and Induces Apoptosis and Cell Cycle Arrest Through the Modulation of Akt/FoxO Signaling in Human Colorectal Cancer Cells

  2012cited by this paper
• PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.

  2012cited by this paper
• Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/β-Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair

  2012cited by this paper
• Mammalian target of rapamycin signaling in diabetic cardiovascular disease

  2012influential reference
• The pharmacological importance of agmatine in the brain.

  2012cited by this paper
• From oxygen to erythropoietin: relevance of hypoxia for retinal development, health and disease.

  2012cited by this paper
• Vitamin E renders protection to PC12 cells against oxidative damage and apoptosis induced by single-walled carbon nanotubes.

  2012cited by this paper
• Erufosine simultaneously induces apoptosis and autophagy by modulating the Akt-mTOR signaling pathway in oral squamous cell carcinoma.

  2012cited by this paper
• Hypoxia Inducible Factor-1: Its Potential Role In Cerebral Ischemia

  2012cited by this paper
• Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.

  2012influential reference
• Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats

  2012cited by this paper
• Effects of Supplemental Erythropoietin on Its Receptor Expression and Signal Transduction Pathways in Rat Model of Retinal Detachment

  2012cited by this paper
• Inhibition of Protein Tyrosine Phosphatase Improves Angiogenesis via Enhancing Ang-1/Tie-2 Signaling in Diabetes

  2012cited by this paper
• Simultaneous modulation of COX‐2, p300, Akt, and Apaf‐1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells

  2012cited by this paper
• System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo.

  2012cited by this paper
• Corrigendum to “Proline-rich Akt substrate of 40 kDa (PRAS40): A novel downstream target of PI3k/Akt signaling pathway” [Cell. Signal. 2012; 24:17–24]

  2012cited by this paper
• Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer's disease model.

  2012cited by this paper
• NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivity

  2012cited by this paper
• Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL

  2012cited by this paper
• Metabotropic glutamate receptors and interacting proteins: evolving drug targets.

  2012cited by this paper
• SIRT1: new avenues of discovery for disorders of oxidative stress

  2012cited by this paper
• Erythropoietin mediated bone formation is regulated by mTOR signaling

  2012cited by this paper
• Glutamate signaling in the pathophysiology and therapy of prenatal insults.

  2012cited by this paper
• Organ-protective and immunomodulatory effects of erythropoietin--an update on recent clinical trials.

  2012cited by this paper
• Asialoerythropoietin, a Nonerythropoietic Derivative of Erythropoietin, Displays Broad Anti-Heart Failure Activity

  2012cited by this paper
• Nicotinamide prevents the down-regulation of MEK/ERK/p90RSK signaling cascade in brain ischemic injury.

  2012cited by this paper
• Erythropoietin in neonatal brain protection: the past, the present and the future.

  2011cited by this paper
• Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats.

  2011cited by this paper
• Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy

  2011cited by this paper
• Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress.

  2011cited by this paper
• Erythropoietin protects against apoptosis and increases expression of non‐neuronal cell markers in the hypoxia‐injured developing brain

  2011cited by this paper
• Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.

  2011cited by this paper
• β Common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase

  2011cited by this paper
• Oxidative stress and diabetes mellitus

  2011cited by this paper
• Regulation of caspases in the nervous system implications for functions in health and disease.

  2011cited by this paper
• Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP(+)) model of Parkinson's disease.

  2011cited by this paper
• Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.

  2011cited by this paper
• Erythropoietin and the heart: facts and perspectives.

  2011cited by this paper
• EPO improves the proliferation and inhibits apoptosis of trophoblast and decidual stromal cells through activating STAT-5 and inactivating p38 signal in human early pregnancy.

  2011cited by this paper
• Effects of mesenchymal stem cells on matrix metalloproteinase synthesis in cardiac fibroblasts

  2011cited by this paper
• Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice.

  2011cited by this paper
• Erythropoietin protects against doxorubicin-induced heart failure.

  2011cited by this paper
• Erythropoietin and Wnt1 govern pathways of mTOR, Apaf-1, and XIAP in inflammatory microglia.

  2011influential reference
• Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury

  2011cited by this paper
• Multi-target-directed ligands in Alzheimer's disease treatment.

  2011cited by this paper
• EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3β, and β-catenin to foster vascular integrity during experimental diabetes.

  2011cited by this paper
• L-DOPA neurotoxicity is prevented by neuroprotective effects of erythropoietin.

  2011cited by this paper
• Nicotinamide Inhibits Alkylating Agent-Induced Apoptotic Neurodegeneration in the Developing Rat Brain

  2011cited by this paper
• Protective Function of Nicotinamide Against Ketamine-induced Apoptotic Neurodegeneration in the Infant Rat Brain

  2011cited by this paper
• Erythropoietin: A Hormone with Multiple Functions

  2011cited by this paper
• Endogenous erythropoietin from astrocyte protects the oligodendrocyte precursor cell against hypoxic and reoxygenation injury

  2011cited by this paper
• High glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy.

  2011cited by this paper
• Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus

  2011cited by this paper
• Translating cell survival and cell longevity into treatment strategies with SIRT1.

  2011cited by this paper
• Gypenoside attenuates white matter lesions induced by chronic cerebral hypoperfusion in rats.

  2011cited by this paper
• Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases.

  2011cited by this paper
• A novel cardioprotective p38-MAPK/mTOR pathway.

  2011cited by this paper
• Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury.

  2011cited by this paper
• The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression

  2011cited by this paper
• ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.

  2010cited by this paper
• Hydrogen peroxide inhibits mTOR signaling by activation of AMPKα leading to apoptosis of neuronal cells

  2010cited by this paper
• Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation.

  2010cited by this paper
• Oxidative stress: Biomarkers and novel therapeutic pathways

  2010cited by this paper
• egulation of neural stem / progenitor cell maintenance by PI 3 K and mTOR

  2010cited by this paper
• Oxidative stress in diabetic nephropathy.

  2010cited by this paper
• Erythropoietin prevents reactive oxygen species generation and renal tubular cell apoptosis at high glucose level.

  2010cited by this paper
• MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

  2010cited by this paper
• Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress.

  2010cited by this paper
• Erythropoietin Improves the Survival of Fat Tissue after Its Transplantation in Nude Mice

  2010cited by this paper
• A novel mTOR activating protein protects dopamine neurons against oxidative stress by repressing autophagy related cell death

  2010cited by this paper
• Darbepoetin-α treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model.

  2010cited by this paper
• The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons.

  2010cited by this paper
• Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders

  2010cited by this paper
• Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways.

  2010cited by this paper
• FOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling.

  2010cited by this paper
• Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?

  2010cited by this paper
• Growth factors in ischemic stroke

  2009cited by this paper
• New strategies for Alzheimer disease and cognitive impairment

  2009cited by this paper
• The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3.

  2009cited by this paper
• Tuberous Sclerosis Complex Activity Is Required to Control Neuronal Stress Responses in an mTOR-Dependent Manner

  2009cited by this paper
• FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis.

  2009cited by this paper
• Hypertension Induced by Erythropoietin Has a Correlation With Truncated Erythropoietin Receptor mRNA in Endothelial Progenitor Cells of Hemodialysis Patients

  2009cited by this paper
• The Vitamin Nicotinamide: Translating Nutrition into Clinical Care

  2009cited by this paper
• Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide‐treated human renal proximal tubular cells by alpha‐erythropoietin

  2009cited by this paper
• mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia*

  2009cited by this paper
• Raves and risks for erythropoietin.

  2008cited by this paper
• Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.

  2008cited by this paper
• The mTOR target 4E‐BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency

  2008cited by this paper
• Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5

  2008cited by this paper
• The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.

  2008cited by this paper
• OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.

  2008cited by this paper
• Life Span Extension and Neuronal Cell Protection by Drosophila Nicotinamidase*

  2008cited by this paper
• Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function

  2007cited by this paper
• Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathway

  2007cited by this paper
• PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding*

  2007influential reference
• The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection.

  2007cited by this paper
• The Effects of mTOR-Akt Interactions on Anti-apoptotic Signaling in Vascular Endothelial Cells*

  2007cited by this paper
• An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.

  2007cited by this paper
• PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.

  2007influential reference
• The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury.

  2007cited by this paper

• An Overview of Neuroprotective Effects of Erythropoietin Against Neurological Disorders: Beyond Erythropoiesis

  2025cites this paper
• Neuroprotective and Anti-inflammatory Effects of Monotropein Against Cerebral Infarction Induced in Experimental Animals and SH-SY5Y Cells

  2025cites this paper
• Comprehensive Analysis of Kisspeptin Signaling: Effects on Cellular Dynamics in Cervical Cancer

  2024cites this paper
• Cognitive Impairment in Multiple Sclerosis

  2023cites this paper
• The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.

  2023cites this paper
• Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System

  2023cites this paper
• Cornerstone Cellular Pathways for Metabolic Disorders and Diabetes Mellitus: Non-Coding RNAs, Wnt Signaling, and AMPK

  2023cites this paper
• The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk

  2023cites this paper
• Biphasic effects of statins on neuron cell functions under oxygen–glucose deprivation and normal culturing conditions via different mechanisms

  2022cites this paper
• The role of the mTOR pathway in diabetic retinopathy

  2022cites this paper
• A Common Link in Neurovascular Regenerative Pathways: Protein Kinase B (Akt).

  2022cites this paper
• Sirtuins in metabolic disease: innovative therapeutic strategies with SIRT1, AMPK, mTOR, and nicotinamide

  2021cites this paper
• Novel treatment strategies for neurodegenerative disease with sirtuins

  2021cites this paper
• Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm

  2021cites this paper
• Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer’s disease

  2021cites this paper
• The Molecular Landscape and Biological Alterations Induced by PRAS40-Knockout in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways

  2021cites this paper
• Targeting PRAS40: a novel therapeutic strategy for human diseases

  2021influential citation
• Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

  2021cites this paper
• Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1

  2020cites this paper
• The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment

  2020influential citation
• Aescin Protects Neuron from Ischemia-Reperfusion Injury via Regulating the PRAS40/mTOR Signaling Pathway

  2020cites this paper
• Nicotinamide: Oversight of Metabolic Dysfunction through SIRT1, mTOR, and Clock Genes.

  2020cites this paper
• Dysregulation of metabolic flexibility: The impact of mTOR on autophagy in neurodegenerative disease.

  2020cites this paper
• New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.

  2020cites this paper
• A preliminary report: genistein attenuates cerebral ischemia injury in ovariectomized rats via regulation of the PI3K-Akt-mTOR pathway.

  2019influential citation
• Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways

  2019cites this paper
• Novel Pathways of Autophagy for the Treatment of Nervous System Disorders

  2018cites this paper
• Cortical and hippocampal expression of inflammatory and intracellular signaling proteins in aged rats submitted to aerobic and resistance physical training

  2018cites this paper
• Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.

  2017cites this paper
• Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.

  2017cites this paper
• Synthesis of microgel sensors for spatial and temporal monitoring of protease activity.

  2017cites this paper
• PRAS40 signaling in tumor

  2017cites this paper
• Aerobic exercise in adolescence results in an increase of neuronal and non-neuronal cells and in mTOR overexpression in the cerebral cortex of rats.

  2017cites this paper
• Recombinant Human Erythropoietin Protects Against Hippocampal Damage in Developing Rats with Seizures by Modulating Autophagy via the S6 Protein in a Time-Dependent Manner

  2017cites this paper
• Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases.

  2016cites this paper
• Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

  2016cites this paper
• MLIF Alleviates SH-SY5Y Neuroblastoma Injury Induced by Oxygen-Glucose Deprivation by Targeting Eukaryotic Translation Elongation Factor 1A2

  2016cites this paper
• mTOR Signaling in Parkinson’s Disease

  2016cites this paper
• Targeting PRAS40 for multiple diseases.

  2016cites this paper
• Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR

  2016influential citation
• Regeneration in the nervous system with erythropoietin.

  2016cites this paper
• Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.

  2016cites this paper
• Regeneration in the nervous system with erythropoietin.

  2016cites this paper
• Charting a course for erythropoietin in traumatic brain injury.

  2016cites this paper
• mTOR: Exploring a New Potential Therapeutic Target for Stroke

  2016cites this paper
• Novel Stem Cell Strategies with mTOR

  2016cites this paper
• mTOR, Autophagy, Aminoacidopathies, and Human Genetic Disorders

  2016cites this paper
• mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.

  2015cites this paper
• Stem cell guidance through the mechanistic target of rapamycin.

  2015cites this paper
• Erythropoietin and diabetes mellitus.

  2015cites this paper
• FoxO Proteins in the Nervous System

  2015cites this paper
• Genetic ablation of PRAS40 improves glucose homeostasis via linking the AKT and mTOR pathways.

  2015cites this paper
• Cystathionine β-Synthase Inhibition Is a Potential Therapeutic Approach to Treatment of Ischemic Injury

  2015cites this paper
• Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer.

  2015cites this paper
• Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease

  2015influential citation
• Programming apoptosis and autophagy with novel approaches for diabetes mellitus.

  2015cites this paper
• mTOR: A Novel Therapeutic Target for Diseases of Multiple Systems.

  2015cites this paper
• Tryptophan and Cell Death

  2015cites this paper
• New Insights for Oxidative Stress and Diabetes Mellitus

  2015cites this paper
• Driving neural regeneration through the mammalian target of rapamycin

  2014cites this paper
• PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways.

  2014cites this paper
• Cutting through the complexities of mTOR for the treatment of stroke.

  2014influential citation
• Phosphorylation of PRAS40‐Thr246 Involved in Renal Lipid Accumulation of Diabetes

  2014cites this paper
• Taking aim at Alzheimer's disease through the mammalian target of rapamycin

  2014cites this paper
• WISP1: Clinical insights for a proliferative and restorative member of the CCN family.

  2014cites this paper
• Targeting erythropoietin for chronic neurodegenerative diseases

  2013cites this paper
• Novel directions for diabetes mellitus drug discovery

  2013cites this paper
• The rationale of targeting mammalian target of rapamycin for ischemic stroke.

  2013cites this paper
• Therapeutic targets for cancer: Current concepts with PI 3-K, Akt, & mTOR

  2013cites this paper
• Phospho-mTOR: a novel target in regulation of renal lipid metabolism abnormality of diabetes.

  2013cites this paper
• mTOR: on target for novel therapeutic strategies in the nervous system.

  2013cites this paper
• A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

  2012cites this paper
• WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1.

  2012cites this paper
• Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade

  2012influential citation
• Title : A preliminary report : Genistein Attenuates Cerebral Ischemia Injury in Ovariectomized Rats via Regulation of the PI 3 K-Akt-mTOR Pathway Running title : Genistein Attenuates Cerebral Ischemia Injury

  year unknowncites this paper